Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced the completion of an extensive market research study conducted in partnership with Thrivable, a cardiometabolic patient insights company that designs and conducts research with highly engaged members of the diabetes community.

Thrivable combines a proprietary community of people living with cardiometabolic conditions with a dedicated research team to generate patient-centric insights through direct engagement. Thrivable helps healthcare companies better understand the daily experiences, burdens, and unmet needs of people living with diabetes and other chronic conditions.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.